Gasotransmitters in cancer

From pathophysiology to experimental therapy

    Research output: Contribution to journalArticle

    133 Citations (Scopus)

    Abstract

    The three endogenous gaseous transmitters-nitric oxide (NO), carbon monoxide (CO) and hydrogen sulfide (H 2 S)-regulate a number of key biological functions. Emerging data have revealed several new mechanisms for each of these three gasotransmitters in tumour biology. It is now appreciated that they show bimodal pharmacological character in cancer, in that not only the inhibition of their biosynthesis but also elevation of their concentration beyond a certain threshold can exert anticancer effects. This Review discusses the role of each gasotransmitter in cancer and the effects of pharmacological agents-some of which are in early-stage clinical studies-that modulate the levels of each gasotransmitter. A clearer understanding of the pharmacological character of these three gases and the mechanisms underlying their biological effects is expected to guide further clinical translation.

    Original languageEnglish (US)
    Pages (from-to)185-203
    Number of pages19
    JournalNature Reviews Drug Discovery
    Volume15
    Issue number3
    DOIs
    StatePublished - Mar 1 2016

    Fingerprint

    Gasotransmitters
    Investigational Therapies
    Pharmacology
    Neoplasms
    Hydrogen Sulfide
    Carbon Monoxide
    Nitric Oxide
    Gases

    ASJC Scopus subject areas

    • Drug Discovery
    • Pharmacology

    Cite this

    Gasotransmitters in cancer : From pathophysiology to experimental therapy. / Szabo, Csaba.

    In: Nature Reviews Drug Discovery, Vol. 15, No. 3, 01.03.2016, p. 185-203.

    Research output: Contribution to journalArticle

    @article{f0864e83b97f43a7b6dfe92251ba0d50,
    title = "Gasotransmitters in cancer: From pathophysiology to experimental therapy",
    abstract = "The three endogenous gaseous transmitters-nitric oxide (NO), carbon monoxide (CO) and hydrogen sulfide (H 2 S)-regulate a number of key biological functions. Emerging data have revealed several new mechanisms for each of these three gasotransmitters in tumour biology. It is now appreciated that they show bimodal pharmacological character in cancer, in that not only the inhibition of their biosynthesis but also elevation of their concentration beyond a certain threshold can exert anticancer effects. This Review discusses the role of each gasotransmitter in cancer and the effects of pharmacological agents-some of which are in early-stage clinical studies-that modulate the levels of each gasotransmitter. A clearer understanding of the pharmacological character of these three gases and the mechanisms underlying their biological effects is expected to guide further clinical translation.",
    author = "Csaba Szabo",
    year = "2016",
    month = "3",
    day = "1",
    doi = "10.1038/nrd.2015.1",
    language = "English (US)",
    volume = "15",
    pages = "185--203",
    journal = "Nature Reviews Drug Discovery",
    issn = "1474-1776",
    publisher = "Nature Publishing Group",
    number = "3",

    }

    TY - JOUR

    T1 - Gasotransmitters in cancer

    T2 - From pathophysiology to experimental therapy

    AU - Szabo, Csaba

    PY - 2016/3/1

    Y1 - 2016/3/1

    N2 - The three endogenous gaseous transmitters-nitric oxide (NO), carbon monoxide (CO) and hydrogen sulfide (H 2 S)-regulate a number of key biological functions. Emerging data have revealed several new mechanisms for each of these three gasotransmitters in tumour biology. It is now appreciated that they show bimodal pharmacological character in cancer, in that not only the inhibition of their biosynthesis but also elevation of their concentration beyond a certain threshold can exert anticancer effects. This Review discusses the role of each gasotransmitter in cancer and the effects of pharmacological agents-some of which are in early-stage clinical studies-that modulate the levels of each gasotransmitter. A clearer understanding of the pharmacological character of these three gases and the mechanisms underlying their biological effects is expected to guide further clinical translation.

    AB - The three endogenous gaseous transmitters-nitric oxide (NO), carbon monoxide (CO) and hydrogen sulfide (H 2 S)-regulate a number of key biological functions. Emerging data have revealed several new mechanisms for each of these three gasotransmitters in tumour biology. It is now appreciated that they show bimodal pharmacological character in cancer, in that not only the inhibition of their biosynthesis but also elevation of their concentration beyond a certain threshold can exert anticancer effects. This Review discusses the role of each gasotransmitter in cancer and the effects of pharmacological agents-some of which are in early-stage clinical studies-that modulate the levels of each gasotransmitter. A clearer understanding of the pharmacological character of these three gases and the mechanisms underlying their biological effects is expected to guide further clinical translation.

    UR - http://www.scopus.com/inward/record.url?scp=84959352390&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84959352390&partnerID=8YFLogxK

    U2 - 10.1038/nrd.2015.1

    DO - 10.1038/nrd.2015.1

    M3 - Article

    VL - 15

    SP - 185

    EP - 203

    JO - Nature Reviews Drug Discovery

    JF - Nature Reviews Drug Discovery

    SN - 1474-1776

    IS - 3

    ER -